Analysis of Revenues
Revenues as Reported
DexCom Inc., income statement, revenues
US$ in thousands
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
Total revenue exhibits a consistent and strong upward trajectory from 2018 through 2022, increasing from $1,031.6 million to $2,909.8 million. This growth is characterized by steady gains in both domestic and international segments.
- Aggregate Revenue Growth
- Total revenue grew annually throughout the analyzed period. The growth rate was most pronounced between 2018 and 2019, with a subsequent trend of steady but decelerating percentage increases through 2022.
- United States Market Dynamics
- Domestic revenue remains the dominant source of income, rising from $818.4 million in 2018 to $2.14 billion in 2022. The US market shows a pattern of consistent absolute growth, although the rate of increase has tapered over time.
- International Market Trajectory
- Revenue from markets outside the United States grew from $213.2 million in 2018 to $767.8 million in 2022. International growth has been more aggressive relative to its starting base than domestic growth, indicating successful global expansion.
- Revenue Mix Shift
- An observable trend toward geographic diversification is present. The United States' share of total revenue declined from approximately 79.3% in 2018 to 73.6% in 2022, while the contribution from international markets grew correspondingly.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?